Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where O. Munck is active.

Publication


Featured researches published by O. Munck.


Scandinavian Journal of Clinical & Laboratory Investigation | 1966

The Fat Content of Leg Muscles and its Influence on the 133Xenon Clearance Method of Blood-Flow Measurement

L. F. Lindjerg; Anne Marie Andersen; O. Munck; M. Jørgensen

The inert gas xenon, which is widely employed for organ blood-flow measurement, is highly soluble in lipids. The removal rate of xenon from an organ is therefore largely influenced by the fat content of the tissue.


Scandinavian Journal of Clinical & Laboratory Investigation | 1967

Decomposition of iodine-labelled antipyrine.

O. Munck; Anne Marie Andersen

The radiochemical stability of 4-iodoantipyrine-123 and 4-iodo-antipyrine-123I was examined under different circumstances by paper chromatography. The essential conclusions were (1) Use preferably the 123I-labelled compound. (2) Dilute the compound with water and not with saline. (3) Analyse each batch for radiochemical purity. (4) Although temperature is not a major factor in the decomposition of 4-iodoantipyrine storage at the lowest convenient temperature is advisable. (5) Purify the 131I-labelled compound before use.


Scandinavian Journal of Clinical & Laboratory Investigation | 1975

[131I]Hippuran renography in normal subjects and in patients with essential hypertension.

P. Mogensen; O. Munck; J. Giese

Seventeen normal subjects and 21 patients with essential hypertension were examined by [131I]hippuran renography. Both groups were studied twice on the same day, first in a state of moderate dehydration and then after rehydration. From these data, four sets of reference intervals were established for several renographic parameters. Differences between the two groups were defined. The most impressive observation was a greater functional disparity between the two kidneys of one individual in the group of hypertensive patients, particularly when in a state of moderate volume depletion. This was reflected in a greater variance of certain kidney-to-kidney ratios derived from the renographic tracings. This article presents basic data to be utilized in clinical renography, as described in an accompanying article.


Scandinavian Journal of Clinical & Laboratory Investigation | 1975

Fractional Intestinal Absorption and Retention of Calcium Measured by Whole-Body Counting. Application of a Power Function Model

S. Pors Nielsen; O. Bärenholdt; O. Munck

By application of a power function model, fractional intestinal calcium absorption was investigated with a new technique involving whole-body counting after successive oral and intravenous administration of standard doses of 47Ca. The fractional calcium retention 7 days after the oral load of 47Ca was also measured. Fractional calcium retention averaged 30.3% in normal subjects and 11.5% in 11 patients with intestinal malabsorption. In the same groups fractional calcium absorption averaged 46.6% and 16.4%, respectively. Fractional calcium retention and intestinal calcium absorption were significantly correlated to body surface area, and there was a well-defined relation between fractional retention and absorption of calcium...


Scandinavian Journal of Clinical & Laboratory Investigation | 1975

Diagnostic Value of Renography for Detection of Unilateral Renal or Renovascular Disease in Hypertensive Patients

J. Giese; P. Mogensen; O. Munck

In an effort to find an optimal set of renographic reference parameters for the study of hypertensive patients, the renographic data from 50 hypertensive patients with unilateral renal or renovascular disease were assessed against 95% confidence intervals obtained in normal subjects and in patients with essential hypertension in two different states of hydration. The highest all-over nosographic sensitivity and specificity were obtained by using the data from hydrated normal subjects as reference parameters. The nosographic sensitivity and specificity found in the selected series of hypertensive patients were converted to the clinically relevant predictive values of a positive and a negative test by assuming the prevalence of unilateral renal or renovascular disease in hospital populations of hypertensive patients to be 5% or 10%. In these model populations the predictive value of a postive was 33% and 51%, respectively. The predictive value of a negative test was higher than 99% for both populations. We find that predictive values of that order of magnitude are satisfactory for a test to be used in the initial phase of a diagnostic process.


Calcified Tissue International | 1975

Calcium metabolism in patients with chronic non-dialytic renal disease

S. Pors Nielsen; O. Helmer Sørensen; B. Lund; O. Bärenholdt; O. Munck; Knud Søndertoft Pedersen

Calcium metabolism was evaluated in 81 patients with chronic non-dialytic renal disease. Bone mineral content measured by photon absorptiometry was significantly lower than in normals, and serum alkaline phosphatase levels higher than in normals. However, the differences were small indicating that the calcium-metabolic disturbance was moderate. None of the patients suffered from overt osteomalacia.The mean serum level of 25-hydroxy-cholecalciferol (25-OH-D3) was slightly, but significantly higher than in normals studied at the same time of the year, but some patients and subnormal 25-OH-D3 levels. One such patient was given a daily dose of 1200 U of vitamin D3 by mouth for 3 weeks. Hereafter, the serum 25-OH-D3 concentration rose progressively to high normal values. These two observations would suggest that the hepatic 25-hydroxylation in such patients is unimpaired.The results are in accordance with the existence of a subclinical vitamin D deficiency in patients with non-dialytic renal disease, due to an impaired production of 1,25-(OH)2D3. It is an open question whether such patients should be given (prophylactic) treatment with 1α-hydroxycholecalciferol.


Scandinavian Journal of Clinical & Laboratory Investigation | 1986

The function of a continuous medication system in subatmospheric pressure environment

Else Hjortsø; Henrik Jordening; Henning Tarp Jensen; O. Munck; Jesper Qvist

The pumping rate of Alzet mini-osmotic pumps was examined in different environments by use of 125J-hippuran. There was a marked increase in pumping rate under hypobaric conditions (PB = 360 mmHg = 48kPa).


Scandinavian Journal of Clinical & Laboratory Investigation | 1973

Treatment of Osteoporosis with Calcium Infusions an Osteodensitometric Study

H. Jensen; Claus Christiansen; O. Munck; H. Toft

It has recently been suggested that osteoporosis results from an imbalance between the secretion of parathyroid hormone and thyrocalcitonin, resulting in a net loss of calcium, and that intermittent hypercalcaemia might reverse this imbalance. This hypothesis was tested in five women with postmenopausal osteoporosis by giving 12 calcium infusions on 12 consecutive days. The bone mineral content was measured by means of osteodensitometry, which was performed at regular intervals before, during, and after the infusions. The treatment did not result in any significant alteration in bone mineral content.


The Lancet | 1975

Letter: 25-Hydroxycholecalciferol in chronic renal failure.

Birger Lund; Sorensen Oh; Nielsen Sp; O. Munck; O. Bärenholdt; Kamille Dumong Petersen


The Lancet | 1975

25-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILURE

Birger Lund; O. Helmer S o̸ rensen; S. Pors Nielsen; O. Munck; O. Bärenholdt; Kamille Dumong Petersen

Collaboration


Dive into the O. Munck's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Birger Lund

Frederiksberg Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge